ask="6.25"
ask_size="1000"
average_daily_volume="1208390"
bid="5.97"
bid_size="100"
book_value="0.05"
change="+0.73"
change_from_200_day_moving_average="0.98"
change_from_50_day_moving_average="0.21"
change_from_52_week_high="-1.32"
change_From_52_week_low="4.29"
change_in_percent="+13.25%"
close="6.24"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-57.26M"
eps_estimate_current_year="-0.87"
eps_estimate_next_quarter="-0.17"
eps_estimate_next_year="-0.88"
ex_dividend_date="N/A"
float_shares="46578000"
high="6.46"
high_52_weeks="7.56"
last_trade_date="2/28/2017"
last_trade_price="6.24"
last_trade_size="N/A"
last_trade_time="4:00pm"
low="5.40"
low_52_weeks="1.95"
market_capitalization="460.25M"
moving_average_200_day="5.26"
moving_average_50_day="6.03"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.25"
open="5.47"
pe_ratio="N/A"
peg_ratio="-0.32"
percent_change_from_200_day_moving_average="+18.60%"
percent_change_from_50_day_moving_average="+3.56%"
percent_change_from_52_week_high="-17.46%"
percent_change_from_52_week_low="+220.00%"
previous_close="5.51"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="102.04"
price_per_sales="18.50"
revenue="21.97M"
shares_outstanding="73758000"
short_ratio="8.88"
stock_exchange="NMS"
symbol="BCRX"
volume="6471608"
weeks_range_52="1.95 - 7.56"
